Skip to main content

Validation of an Automated Latex Particle-Enhanced Immunoturbidimetric von Willebrand Factor Activity Assay.

Chen D, Tange JI, Meyers BJ, Pruthi RK, Nichols WL, Heit JA

Publication: J Thromb Haemost (2011) • Vol 9 • Page 1993PMID: 21824283View on PubMed

Purpose

The purpose of this paper was to evaluate the latex particle enhanced immunoturbidimetric assay for von Willebrand factor (VWF:Lx) for diagnosis of von Willebrand disease (VWD).

Conclusion

Measurement of VWF by VWF:Lx was not affected by storage of plasma at room temperature for up to 8 h. The authors report occasional interference with the VWF:Lx assay by severe hyperlipemia, hyperbilirubinemia, hemolysis, and from platelets in previously frozen specimens with more than 500,000 platelets/uL. Both VWF:Lx and VWF ristocetin cofactor activity assay (VWF:RCo) properly classified most normal and VWD individuals, but VWF:Lx was more sensitive.

Studies (1)

Purpose

The purpose of this study was to determine the effects of storage and assay type on the diagnosis of VWD.

Summary of Findings

The coefficient of variance (CV) of VWF:Lx was less than 10% between plasma collected over 21 days and between 2 plasma specimens measured fresh and stored for up to 8 h at room temperature. The authors report occasional interference with VWF:Lx from specimens with severe hyperlipemia, hyperbilirubinemia, hemolysis, and more than 500,000 platelets/uL in previously frozen specimens. A high degree of correlation in VWF activity was found between VWF:Lx and VWF:RCo (R2=0.93, P<0.001). Both assays properly classified 357 of 368 normal individuals with 11 individual classified as having low VWF. Of 57 specimens from individuals with type 1 VWD, 46 and 48 specimens were properly assigned by VWF:RCo and VWF:Lx, respectively. Among the 35 plasma specimens collected from patients with type 2 (A/B or M) VWD, 3 and 4 were missclassified as normal using the VWF:Lx and VWF:RCo, respectively; however, 4 of these were grossly lipemic. There were 8 specimens that were not initially distinguished as being severe type 1 or type 2M VWD. Using flow cytometry, 6 of these were classified as type 2M of which 5 had VWF:Lx measurements that were less than 70% of actual VWF levels . VWF:Lx was 92% sensitive at detecting acquired VWF abnormality, while VWF:RCo was 83% sensitive.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Other diagnoses
    Normal
    Not specified
  • Platforms

    ProteinHematology/ auto analyzer
    ProteinClinical chemistry/auto analyzer
    ProteinImmunoturbidometric assay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Hyperbilirubinemia
    Hyperlipemia
    Type 1 von Willebrand disease
    Type 2 A/B von Willebrand disease
    Type 2M von Willebrand disease
    Biospecimen Aliquots and ComponentsBiospecimen components
    Bilirubin
    Hemolysis
    Lipids
    Platelet rich plasma
    Biospecimen Aliquots and ComponentsHemolysis
    Absent
    Present
    StorageTime at room temperature
    0 h
    1 h
    2 h
    3 h
    4 h
    5 h
    6 h
    7 h
    8 h
    Immunoturbidometric assay SpecificTechnology platform
    Latex particle enhanced immunoturbidimetric assay for VWF
    VWF ristocetin cofactor activity assay